Business
20/20 Biolabs' Multi-Cancer Early Detection Blood Test Selected by State of Vermont to Screen up to 4,500 Firefighters
Comprehensive Cancer Screening Initiative Expected to Generate Approximately $500,000 in Testing Revenues to 20/20 from the First Cohort GAITHERSBURG, Md., May 27, 2026 (GLOBE NEWSWIRE) -- 20/20 Biolabs, Inc. (Nasdaq: AIDX) (“20/20 Biolabs” or the “Company”), an early market entrant in AI powered laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases, today announced that its OneTest™ multi-cancer early detection blood (“MCED”) test has been selected
About this update from 20/20 Biolabs, Inc.
[{"type":"image","alt":"20/20 Biolabs Inc.","displaySize":"","headline":null,"caption":"20/20 Biolabs Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":244,"height":159,"url":"https://media.zenfs.com/en/globenewswire.com/d2abb3d4c13adceb39a31a2c97271190"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/vj6D.5WcDNqHtzfFPjjYPA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTI3NA--/https://media.zenfs.com/en/globenewswire.com/d2abb3d4c13adceb39a31a2c97271190","width":244,"height":159},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/vj6D.5WcDNqHtzfFPjjYPA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTI3NA--/https://media.zenfs.com/en/globenewswire.com/d2abb3d4c13adceb39a31a2c97271190","width":244,"height":159}},"lazy":false},{"type":"text","content":"Comprehensive Cancer Screening Initiative Expected to Generate Approximately $500,000 in Testing Revenues to 20/20 from the First Cohort","length":136,"tagName":"p"},{"type":"text","content":"GAITHERSBURG, Md., May 27, 2026 (GLOBE NEWSWIRE) -- 20/20 Biolabs, Inc. (Nasdaq: AIDX) (“20/20 Biolabs” or the “Company”), an early market entrant in AI powered laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases, today announced that its OneTest™ multi-cancer early detection blood (“MCED”) test has been selected as part of a firefighter cancer screening initiative for the state of Vermont in partnership with National Diagnostic Services (“NDS”). NDS will provide ultrasound services and medical oversight in conjunction with 20/20’s OneTest.","length":594,"tagName":"p"},{"type":"text","content":"This twelve-month statewide program is designed to provide eligible firefighters in Vermont with expanded access to proactive cancer screening tools intended to help identify cancer earlier, when treatment outcomes may be improved. The program was established in response to the elevated cancer risks firefighters confront daily due to occupational exposures. The specifications for this important initiative called for a statewide program incorporating multi-cancer early detection blood testing, ultrasound examinations, educational outreach, clinical follow-up, and longitudinal program data collection. The contract is anticipated to generate approximately $500,000 in revenues for 20/20 for testing approximately one-third of eligible Vermont firefighters through the end of 202...